These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36833235)

  • 1. Collagen Network Formation in In Vitro Models of Musculocontractural Ehlers-Danlos Syndrome.
    Hashimoto A; Hirose T; Hashimoto K; Mizumoto S; Nitahara-Kasahara Y; Saka S; Yoshizawa T; Okada T; Yamada S; Kosho T; Watanabe T; Miyata S; Nomura Y
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural alteration of glycosaminoglycan side chains and spatial disorganization of collagen networks in the skin of patients with mcEDS-CHST14.
    Hirose T; Takahashi N; Tangkawattana P; Minaguchi J; Mizumoto S; Yamada S; Miyake N; Hayashi S; Hatamochi A; Nakayama J; Yamaguchi T; Hashimoto A; Nomura Y; Takehana K; Kosho T; Watanabe T
    Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):623-631. PubMed ID: 30553867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Pathophysiology of Musculocontractural Ehlers-Danlos Syndrome.
    Kosho T; Mizumoto S; Watanabe T; Yoshizawa T; Miyake N; Yamada S
    Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31905796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic investigation of the skin in Chst14-/- mice: A model for skin fragility in musculocontractural Ehlers-Danlos syndrome caused by CHST14 variants (mcEDS-CHST14).
    Hirose T; Mizumoto S; Hashimoto A; Takahashi Y; Yoshizawa T; Nitahara-Kasahara Y; Takahashi N; Nakayama J; Takehana K; Okada T; Nomura Y; Yamada S; Kosho T; Watanabe T
    Glycobiology; 2021 Feb; 31(2):137-150. PubMed ID: 32601684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse Models of Musculocontractural Ehlers-Danlos Syndrome.
    Yoshizawa T; Kosho T
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed Courses and Pathological Findings of Colonic Perforation without Diverticula in Sisters with Musculocontractural Ehlers-Danlos Syndrome Caused by Pathogenic Variant in
    Kobayashi T; Fujishima F; Tokodai K; Sato C; Kamei T; Miyake N; Matsumoto N; Kosho T
    Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myopathy Associated With Dermatan Sulfate-Deficient Decorin and Myostatin in Musculocontractural Ehlers-Danlos Syndrome: A Mouse Model Investigation.
    Nitahara-Kasahara Y; Posadas-Herrera G; Mizumoto S; Nakamura-Takahashi A; Inoue YU; Inoue T; Nomura Y; Takeda S; Yamada S; Kosho T; Okada T
    Front Cell Dev Biol; 2021; 9():695021. PubMed ID: 34708033
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathophysiological Investigation of Skeletal Deformities of Musculocontractural Ehlers-Danlos Syndrome Using Induced Pluripotent Stem Cells.
    Yue F; Era T; Yamaguchi T; Kosho T
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36981001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Otological Features of Patients with Musculocontractural Ehlers-Danlos Syndrome Caused by Pathogenic Variants in
    Kawakita M; Iwasaki S; Moteki H; Nishio SY; Kosho T; Usami SI
    Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineation of musculocontractural Ehlers-Danlos Syndrome caused by dermatan sulfate epimerase deficiency.
    Lautrup CK; Teik KW; Unzaki A; Mizumoto S; Syx D; Sin HH; Nielsen IK; Markholt S; Yamada S; Malfait F; Matsumoto N; Miyake N; Kosho T
    Mol Genet Genomic Med; 2020 May; 8(5):e1197. PubMed ID: 32130795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular abnormalities in the placenta of Chst14-/- fetuses: implications in the pathophysiology of perinatal lethality of the murine model and vascular lesions in human CHST14/D4ST1 deficiency.
    Yoshizawa T; Mizumoto S; Takahashi Y; Shimada S; Sugahara K; Nakayama J; Takeda S; Nomura Y; Nitahara-Kasahara Y; Okada T; Matsumoto K; Yamada S; Kosho T
    Glycobiology; 2018 Feb; 28(2):80-89. PubMed ID: 29206923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome.
    Miyake N; Kosho T; Mizumoto S; Furuichi T; Hatamochi A; Nagashima Y; Arai E; Takahashi K; Kawamura R; Wakui K; Takahashi J; Kato H; Yasui H; Ishida T; Ohashi H; Nishimura G; Shiina M; Saitsu H; Tsurusaki Y; Doi H; Fukushima Y; Ikegawa S; Yamada S; Sugahara K; Matsumoto N
    Hum Mutat; 2010 Aug; 31(8):966-74. PubMed ID: 20533528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHST14/D4ST1 deficiency: New form of Ehlers-Danlos syndrome.
    Kosho T
    Pediatr Int; 2016 Feb; 58(2):88-99. PubMed ID: 26646600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular features of 66 patients with musculocontractural Ehlers-Danlos syndrome caused by pathogenic variants in
    Minatogawa M; Unzaki A; Morisaki H; Syx D; Sonoda T; Janecke AR; Slavotinek A; Voermans NC; Lacassie Y; Mendoza-Londono R; Wierenga KJ; Jayakar P; Gahl WA; Tifft CJ; Figuera LE; Hilhorst-Hofstee Y; Maugeri A; Ishikawa K; Kobayashi T; Aoki Y; Ohura T; Kawame H; Kono M; Mochida K; Tokorodani C; Kikkawa K; Morisaki T; Kobayashi T; Nakane T; Kubo A; Ranells JD; Migita O; Sobey G; Kaur A; Ishikawa M; Yamaguchi T; Matsumoto N; Malfait F; Miyake N; Kosho T
    J Med Genet; 2022 Sep; 59(9):865-877. PubMed ID: 34815299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new mouse model of Ehlers-Danlos syndrome generated using CRISPR/Cas9-mediated genomic editing.
    Nitahara-Kasahara Y; Mizumoto S; Inoue YU; Saka S; Posadas-Herrera G; Nakamura-Takahashi A; Takahashi Y; Hashimoto A; Konishi K; Miyata S; Masuda C; Matsumoto E; Maruoka Y; Yoshizawa T; Tanase T; Inoue T; Yamada S; Nomura Y; Takeda S; Watanabe A; Kosho T; Okada T
    Dis Model Mech; 2021 Dec; 14(12):. PubMed ID: 34850861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal manifestations in 12 patients with musculocontractural Ehlers-Danlos syndrome caused by CHST14/D4ST1 deficiency (mcEDS-CHST14).
    Uehara M; Kosho T; Yamamoto N; Takahashi HE; Shimakura T; Nakayama J; Kato H; Takahashi J
    Am J Med Genet A; 2018 Nov; 176(11):2331-2341. PubMed ID: 30195269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defect in dermatan sulfate in urine of patients with Ehlers-Danlos syndrome caused by a CHST14/D4ST1 deficiency.
    Mizumoto S; Kosho T; Hatamochi A; Honda T; Yamaguchi T; Okamoto N; Miyake N; Yamada S; Sugahara K
    Clin Biochem; 2017 Aug; 50(12):670-677. PubMed ID: 28238810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic heterogeneity and clinical variability in musculocontractural Ehlers-Danlos syndrome caused by impaired dermatan sulfate biosynthesis.
    Syx D; Van Damme T; Symoens S; Maiburg MC; van de Laar I; Morton J; Suri M; Del Campo M; Hausser I; Hermanns-Lê T; De Paepe A; Malfait F
    Hum Mutat; 2015 May; 36(5):535-47. PubMed ID: 25703627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of dermatan sulfate epimerase (DSE) function results in musculocontractural Ehlers-Danlos syndrome.
    Müller T; Mizumoto S; Suresh I; Komatsu Y; Vodopiutz J; Dundar M; Straub V; Lingenhel A; Melmer A; Lechner S; Zschocke J; Sugahara K; Janecke AR
    Hum Mol Genet; 2013 Sep; 22(18):3761-72. PubMed ID: 23704329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations.
    Janecke AR; Li B; Boehm M; Krabichler B; Rohrbach M; Müller T; Fuchs I; Golas G; Katagiri Y; Ziegler SG; Gahl WA; Wilnai Y; Zoppi N; Geller HM; Giunta C; Slavotinek A; Steinmann B
    Am J Med Genet A; 2016 Jan; 170A(1):103-15. PubMed ID: 26373698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.